Betulinic Acid-Doxorubicin-Drug Combination Induced Apoptotic Death via ROS Stimulation in a Relapsed AML MOLM-13 Cell Model.
B-cell lymphoma 2 family of proteins
acute myeloid leukaemia
apoptosis
betulinic acid
doxorubicin
drug combination
reactive oxygen species
Journal
Antioxidants (Basel, Switzerland)
ISSN: 2076-3921
Titre abrégé: Antioxidants (Basel)
Pays: Switzerland
ID NLM: 101668981
Informations de publication
Date de publication:
14 Sep 2021
14 Sep 2021
Historique:
received:
11
07
2021
revised:
27
08
2021
accepted:
07
09
2021
entrez:
28
9
2021
pubmed:
29
9
2021
medline:
29
9
2021
Statut:
epublish
Résumé
In this study, cell death regulation and induction in AML cell line from a relapsed MLL-rearranged cell model (MOLM-13) was investigated with doxorubin (Dox) and betulinic acid (BetA), singly and in combination. CyQUANT Direct
Identifiants
pubmed: 34573088
pii: antiox10091456
doi: 10.3390/antiox10091456
pmc: PMC8471649
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Cell Prolif. 2012 Dec;45(6):487-98
pubmed: 23030059
Mol Cells. 2012 May;33(5):517-24
pubmed: 22526391
Exp Cell Res. 2000 Jul 10;258(1):223-35
pubmed: 10912804
Cell Death Differ. 2006 Aug;13(8):1351-9
pubmed: 16763616
Cell Death Differ. 2010 Mar;17(3):381-97
pubmed: 20019744
Haematologica. 2012 Dec;97(12):1775
pubmed: 23204476
PLoS One. 2014 Aug 22;9(8):e105768
pubmed: 25148076
Cancer Lett. 2003 Feb 20;190(2):165-9
pubmed: 12565171
Biochem Pharmacol. 1999 Apr 1;57(7):727-41
pubmed: 10075079
Cytokine Growth Factor Rev. 2008 Jun-Aug;19(3-4):325-31
pubmed: 18495520
Biochem Pharmacol. 2015 Mar 1;94(1):1-11
pubmed: 25562745
Toxicol Lett. 2003 Jun 5;143(1):1-7
pubmed: 12697374
Genes Dev. 2011 Oct 1;25(19):1999-2010
pubmed: 21979913
J Clin Invest. 1999 Dec;104(12):1655-61
pubmed: 10606616
Sci Rep. 2017 Aug 14;7(1):8062
pubmed: 28808311
J Biol Chem. 2002 Nov 15;277(46):44317-26
pubmed: 12193597
Cell Death Differ. 2017 Aug;24(8):1348-1358
pubmed: 28234359
Biochem Pharmacol. 2010 Nov 15;80(10):1466-77
pubmed: 20709028
Mol Med Rep. 2018 Mar;17(3):4524-4530
pubmed: 29328378
Oncogene. 2007 Feb 26;26(9):1324-37
pubmed: 17322918
J Appl Physiol (1985). 2011 Oct;111(4):1190-8
pubmed: 21778418
Trends Cell Biol. 2015 Jun;25(6):354-63
pubmed: 25759175
Eur J Pharmacol. 2004 Sep 13;498(1-3):71-8
pubmed: 15363977
Oncogene. 2004 Oct 7;23(46):7611-20
pubmed: 15361826
Blood. 1993 Jun 1;81(11):3091-6
pubmed: 7684624
Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18475-80
pubmed: 20937877
Acta Pharmacol Sin. 2012 Dec;33(12):1542-8
pubmed: 23064721
Integr Biol (Camb). 2011 May;3(5):548-59
pubmed: 21403972
Mol Carcinog. 2011 Oct;50(10):760-9
pubmed: 21751259
FEBS Lett. 2009 Dec 17;583(24):3966-73
pubmed: 19850042
Mol Pharmacol. 1994 Apr;45(4):649-56
pubmed: 8183243
Int J Mol Med. 2017 Dec;40(6):1669-1678
pubmed: 29039440
Acta Pharmacol Sin. 2013 May;34(5):625-35
pubmed: 23524572
Cancer Lett. 2007 Jun 18;251(1):132-45
pubmed: 17169485
Cancer Res. 2007 Dec 15;67(24):11848-58
pubmed: 18089815
Int Immunopharmacol. 2010 Aug;10(8):843-9
pubmed: 20430119
Cold Spring Harb Perspect Biol. 2013 Apr 01;5(4):a008714
pubmed: 23545417
Naunyn Schmiedebergs Arch Pharmacol. 2006 Oct;374(1):11-20
pubmed: 16964520
Front Cell Neurosci. 2018 Apr 25;12:95
pubmed: 29922130
J Invest Dermatol. 2000 May;114(5):935-40
pubmed: 10771474
Head Neck. 2003 Sep;25(9):732-40
pubmed: 12953308
Cancer Lett. 2002 Jan 10;175(1):17-25
pubmed: 11734332
Molecules. 2012 Mar 08;17(3):2939-54
pubmed: 22402764
Int J Mol Sci. 2008 Jun;9(6):1096-107
pubmed: 19325847
Autophagy. 2021 Jan;17(1):1-382
pubmed: 33634751
Cancer Res. 2007 Mar 15;67(6):2816-23
pubmed: 17363604
Int J Oncol. 2020 Jul;57(1):113-121
pubmed: 32377726
Cancer Res. 2010 Jan 15;70(2):440-6
pubmed: 20068163
Molecules. 2017 Feb 10;22(2):
pubmed: 28208611
J Exp Med. 2005 Dec 19;202(12):1691-701
pubmed: 16365148
Am J Cancer Res. 2012;2(2):214-21
pubmed: 22485198
PLoS One. 2018 Oct 29;13(10):e0206427
pubmed: 30372478
Drug Discov Today. 2009 Sep;14(17-18):885-90
pubmed: 19520182
Nat Med. 1995 Oct;1(10):1046-51
pubmed: 7489361
Cancer Res. 2001 May 15;61(10):4024-9
pubmed: 11358821
Cancer Res. 1997 Nov 1;57(21):4956-64
pubmed: 9354463
Oncotarget. 2016 Jul 12;7(28):44763-44778
pubmed: 27007056
Annu Rev Pharmacol Toxicol. 2007;47:143-83
pubmed: 17029566
Evid Based Complement Alternat Med. 2016;2016:8942730
pubmed: 27195016
J Biol Chem. 2004 Jun 11;279(24):25535-43
pubmed: 15054096
Leukemia. 2004 Aug;18(8):1406-12
pubmed: 15201849
Clin Cancer Res. 2003 Jul;9(7):2866-75
pubmed: 12855667
Blood. 2005 Aug 15;106(4):1154-63
pubmed: 15870183
Neoplasia. 2005 Feb;7(2):162-70
pubmed: 15802021
Toxicol Lett. 2005 Mar 15;155(3):343-51
pubmed: 15649617
Int J Oncol. 2016 Aug;49(2):753-62
pubmed: 27278553
Toxicology. 2016 Aug 31;370:41-48
pubmed: 27666003
Leuk Res. 2010 Feb;34(2):166-72
pubmed: 19520430
Biochim Biophys Acta. 2013 Dec;1833(12):3448-3459
pubmed: 23770045
J Immunol Methods. 2001 Aug 1;254(1-2):85-98
pubmed: 11406155
Oncogene. 2008 Oct 27;27(50):6398-406
pubmed: 18955968
Haematologica. 1995 Mar-Apr;80(2):98-102
pubmed: 7628759
Nature. 2012 Jan 11;481(7382):506-10
pubmed: 22237025
Cancer Cell. 2012 Apr 17;21(4):547-62
pubmed: 22516262
Free Radic Biol Med. 2017 Mar;104:144-164
pubmed: 28088622
Apoptosis. 2009 Feb;14(2):191-202
pubmed: 19115109